Lee Jennifer J Y, Feldman Brian M, McCrindle Brian W, Li Ping, Yeung Rae Sm, Widdifield Jessica
The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
ICES, Toronto, ON, Canada.
Pediatr Res. 2023 Apr;93(5):1439-1446. doi: 10.1038/s41390-022-02273-8. Epub 2022 Aug 24.
This study evaluated the risk of hypertension, major adverse cardiac events (MACE), and all-cause mortality in Kawasaki disease (KD) patients up to young adulthood.
An inception cohort of 1169 KD patients between 1991 and 2008 from a tertiary-level hospital in Ontario, Canada was linked with health administrative data to ascertain outcomes up to 28 years of follow-up. Their risk was compared with 11,690 matched population comparators. The primary outcome was hypertension and secondary outcomes were MACE and death.
After a median follow-up of 20 years [IQR: 8.3], the cumulative incidence of hypertension and MACE in the KD group was 3.8% (95% CI: 2.5-5.5) and 1.2% (95% CI: 0.6-2.4%), respectively. The overall survival probability in the KD group was 98.6% (95% CI: 97.2-99.3%). Relative to comparators, KD patients were at an increased risk for hypertension [aHR: 2.2 (95% CI: 1.5-3.4)], death [aHR: 2.5 (95% CI: 1.3-5.0)], and MACE [aHR: 10.7 (95% CI: 6.4-17.9)]. For hypertension and MACE, the aHR was the highest following diagnosis and then the excess risk diminished after 16 and 13 years of follow-up, respectively. MACE occurred largely in KD patients with coronary aneurysms [cumulative incidence: 12.8%].
KD patients demonstrated a reassuring cardiac prognosis up to young adulthood with low events and excellent survival. KD patients were at increased risk for hypertension, but this excess risk occurred early and declined with time.
With the current standard of care, KD patients demonstrated favorable cardiac prognosis, with low events of hypertension, MACE, and excellent survival. Hypertension and MACE risk appear to be highest around the time of KD diagnosis. MACE occurred primarily in KD patients with coronary aneurysms. Our findings are reassuring to KD patients, families, and their providers. Our study demonstrated an association between KD exposure and hypertension. This association is relatively novel. Previous studies have remained conflicting if KD contributes to long-term atherosclerotic risk.
本研究评估了川崎病(KD)患者直至青年期发生高血压、主要不良心脏事件(MACE)和全因死亡的风险。
1991年至2008年期间来自加拿大安大略省一家三级医院的1169例KD患者起始队列与卫生行政数据相关联,以确定长达28年随访期的结局。将他们的风险与11690名匹配的人群对照者进行比较。主要结局为高血压,次要结局为MACE和死亡。
中位随访20年[四分位间距:8.3]后,KD组高血压和MACE的累积发病率分别为3.8%(95%置信区间:2.5 - 5.5)和1.2%(95%置信区间:0.6 - 2.4%)。KD组的总体生存概率为98.6%(95%置信区间:97.2 - 99.3%)。相对于对照者,KD患者发生高血压的风险增加[校正风险比:2.2(95%置信区间:1.5 - 3.4)]、死亡风险增加[校正风险比:2.5(95%置信区间:1.3 - 5.0)]以及MACE风险增加[校正风险比:10.7(95%置信区间:6.4 - 17.9)]。对于高血压和MACE,校正风险比在诊断后最高,然后分别在随访16年和13年后超额风险降低。MACE主要发生在患有冠状动脉瘤的KD患者中[累积发病率:12.8%]。
KD患者直至青年期心脏预后良好,事件发生率低且生存率高。KD患者患高血压的风险增加,但这种超额风险在早期出现并随时间下降。
按照当前的治疗标准,KD患者心脏预后良好,高血压、MACE事件发生率低且生存率高。高血压和MACE风险在KD诊断时似乎最高。MACE主要发生在患有冠状动脉瘤的KD患者中。我们的研究结果让KD患者、其家人及其医疗服务提供者放心。我们的研究表明KD暴露与高血压之间存在关联。这种关联相对新颖。之前的研究对于KD是否会导致长期动脉粥样硬化风险仍存在矛盾。